BioUpp — Levée de fonds OC FTS via LITA.co

Lita Business lending Financé

Ce projet est clôturé. L'analyse ci-dessous reflète les informations disponibles au moment de la souscription et n'a pas été mise à jour.

BioUpp — Levée de fonds OC FTS via LITA.co

Avoid

score / 100

Min. ticket

300 €

Amount raised

500 k€

Invest →

À propos

BioUpp is a French deeptech startup founded October 2024, developing biomethanation units to increase biogas production. The company is raising 3M€ in capital (of which 0.5M€ in convertible bonds via Lita) to finalise its industrial pilot and deploy its first customer units by 2027. TRL6 stage, first order signed, technology from 6 years of collaborative research.

Plateforme · 19.0/25

A1 · Statut réglementaire 8.0/8✓ max

agrément AMF licence AMF fonds propres-2023-27 obtained on 10/11/2023, currently valid
Maximum score

A2 · Track Record 3.0/6

Default 7.05% → 3pts (threshold 3-7%)
Delay >6 months 17.91% → 3pts (threshold 15-30%)
Net yield 5.14% vs announced 7-10%: shortfall 1.86pp below lower bound → 3pts
A2 = (3×0.5)+(3×0.3)+(3×0.2) = 3.0/6

A3 · Rigueur de sélection 3.0/4bon

Published selection rate at ~5% (<20%), precise figure provided (fewer than 200 of 3500 applications)
Process description partial, without committee detail or documented borrower KYC

A4 · Santé financière 3.0/4bon

Independent platform operating in France, Belgium and Italy, active since ~2014 (>5 years)
No platform distress signal identified
No known institutional shareholder

A5 · Protection investisseurs 2.0/3

agrément AMF licence → 1pt reflection period 4 days + continuity plan (mandatory)
Segregated accounts presumed compliant with ECSP regulation → 1pt
No secondary market mentioned → 0pt

Projet · 11.0/75 (24.0 brut, red flags −13.0)

B1 · Instrument & Structure 2.0/10faible

B1.1: 2/5 - obligation convertible without real security, undocumented subordination

B1.2: 2/3 - Issuer SAS France clear law

B1.3: 1/2 - No known senior debt, de facto first ranking not registered

B2 · Opérateur & Track record 9.0/15

B2.1: 4/4 - Directors appointed, LinkedIn/public profiles available

B2.2: 4/5 - Experienced team, CEO 25 years industry, CTO biogas expert, but 0 units sold

B2.3: 0/3 - First platform transaction

B2.4: 2/3 - Recent startup, balance sheet unavailable, no proceedings identified

B3 · Garanties & Sûretés 2.0/15faible

B3.1: 2/9 - obligation convertible without real security or documented joint and several guarantee; only implicit non-notarised personal guarantee

B3.2: 1/4 - Startup without balance sheet, guarantor assets not valued

B3.3: 0/2 - Separate bank financing, no partner for crowdfunding tranche

B4 · Structure financière 3.0/15faible

B4.1: 0/5 - taux de couverture de la dette not calculable, pre-revenue, no existing turnover

B4.2: 2/4 - Dilutive contribution 1.3M€ secured plus 1.3M€ non-dilutive out of 5M€ total (~50%)

B4.3: 0/4 - No stress testing, activity just started

B4.4: 1/2 - Non-dilutive financing partially covered, but negative operational cash flow

B5 · Pré-commercialisation 3.0/10faible

2 LOI signed, 1 order executed (study), 3 expressions of interest
Real pipeline but not contracted to sufficient level
First sales expected 2026, no turnover yet

B6 · Permis & Maturité 3.0/5

Activity legally established, patent pending, laureate i-Lab and Women TechEU
Less than one year in existence but sound legal structure and recognised

B7 · Marché & Localisation 2.0/3

Biogas/biomethanation market in strong growth EU, 1548 methanisation units in France
Identifiable solvent demand, competitive prices versus competitors
Regulatory risk and adoption risk

⚠ Alertes détectées · −13 pts déduits

Obligation convertible sans garantie −8 pts

OCA without mortgage or registered privilege - convertible instrument without registered real security: −8 pts

Aucune garantie réelle sur ce projet −5 pts

No real security on OC FTS ~€500K fundraising - no mortgage, pledge, or documented joint and several guarantee: −5 pts

Points forts

✓Founding team experienced, 25 years industrial and scientific experience.

✓i-Lab 2024 winner and Women TechEU 2025, strong institutional recognition.

✓Technology validated at two scales (3L and 20L), robust proof of concept.

✓Real commercial pipeline: 2 LOI signed, 1 order executed with Agriopale.

✓Non-dilutive financing partially secured (BPI, banks, 1.3M€).

Risques identifiés

!Pre-revenue startup founded October 2024, no turnover realised as of fundraising date.

!OCA instrument without real security or documented joint and several guarantee.

!High industrial execution risk: 20L pilot, industrialisation not finalised.

!Complete absence of financial stress testing and calculable DSCR.

!Dependency on successive fundraisings (5M€ then 8-10M€) to reach profitability.

⚠ Avertissement sur les risques

Investir en crowdfunding comporte un risque de perte partielle ou totale du capital, ainsi qu'un risque d'illiquidité. Selon le baromètre France FinTech / Forvis Mazars 2025, 25 à 30 % des projets accusent un retard de plus de 6 mois et 4 à 6 % entraînent une perte définitive. Ne placez jamais plus de 5 à 10 % de votre patrimoine en crowdfunding et diversifiez sur au moins 10 projets. CrowdPickr est un service d'information indépendant, non agréé en tant que conseiller en investissement. Les analyses présentées ne constituent pas un conseil en investissement personnalisé.